Versatile Design of Organic Polymeric Nanoparticles for Photodynamic Therapy of Prostate Cancer
© 2023 The Authors. Published by American Chemical Society..
Radical prostatectomy is a primary treatment option for localized prostate cancer (PCa), although high rates of recurrence are commonly observed postsurgery. Photodynamic therapy (PDT) has demonstrated efficacy in treating nonmetastatic localized PCa with a low incidence of adverse events. However, its limited efficacy remains a concern. To address these issues, various organic polymeric nanoparticles (OPNPs) loaded with photosensitizers (PSs) that target prostate cancer have been developed. However, further optimization of the OPNP design is necessary to maximize the effectiveness of PDT and improve its clinical applicability. This Review provides an overview of the design, preparation, methodology, and oncological aspects of OPNP-based PDT for the treatment of PCa.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
---|---|
Enthalten in: |
ACS materials Au - 4(2024), 1 vom: 10. Jan., Seite 14-29 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ling, Jiacheng [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 16.01.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1021/acsmaterialsau.3c00060 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367124688 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367124688 | ||
003 | DE-627 | ||
005 | 20240116232044.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240115s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1021/acsmaterialsau.3c00060 |2 doi | |
028 | 5 | 2 | |a pubmed24n1261.xml |
035 | |a (DE-627)NLM367124688 | ||
035 | |a (NLM)38221923 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ling, Jiacheng |e verfasserin |4 aut | |
245 | 1 | 0 | |a Versatile Design of Organic Polymeric Nanoparticles for Photodynamic Therapy of Prostate Cancer |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 16.01.2024 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. Published by American Chemical Society. | ||
520 | |a Radical prostatectomy is a primary treatment option for localized prostate cancer (PCa), although high rates of recurrence are commonly observed postsurgery. Photodynamic therapy (PDT) has demonstrated efficacy in treating nonmetastatic localized PCa with a low incidence of adverse events. However, its limited efficacy remains a concern. To address these issues, various organic polymeric nanoparticles (OPNPs) loaded with photosensitizers (PSs) that target prostate cancer have been developed. However, further optimization of the OPNP design is necessary to maximize the effectiveness of PDT and improve its clinical applicability. This Review provides an overview of the design, preparation, methodology, and oncological aspects of OPNP-based PDT for the treatment of PCa | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
700 | 1 | |a Gu, Rongrong |e verfasserin |4 aut | |
700 | 1 | |a Liu, Lulu |e verfasserin |4 aut | |
700 | 1 | |a Chu, Ruixi |e verfasserin |4 aut | |
700 | 1 | |a Wu, Junchao |e verfasserin |4 aut | |
700 | 1 | |a Zhong, Rongfang |e verfasserin |4 aut | |
700 | 1 | |a Ye, Sheng |e verfasserin |4 aut | |
700 | 1 | |a Liu, Jian |e verfasserin |4 aut | |
700 | 1 | |a Fan, Song |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ACS materials Au |d 2021 |g 4(2024), 1 vom: 10. Jan., Seite 14-29 |w (DE-627)NLM333785215 |x 2694-2461 |7 nnns |
773 | 1 | 8 | |g volume:4 |g year:2024 |g number:1 |g day:10 |g month:01 |g pages:14-29 |
856 | 4 | 0 | |u http://dx.doi.org/10.1021/acsmaterialsau.3c00060 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 4 |j 2024 |e 1 |b 10 |c 01 |h 14-29 |